These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 500317)

  • 21. Chemotherapy and vitamin E in treatment of Nb rat prostate tumors.
    Drago JR; Nesbitt JA; Badalament RA; Smith J
    In Vivo; 1988; 2(6):399-401. PubMed ID: 2979862
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemotherapy of Nb rat adenocarcinoma of the prostate heterotransplanted into congenitally athymic (nude) mice: report of 5-fluorouracil and cyclophosphamide.
    Drago JR; Maurer RE; Gershwin ME; Eckels DD; Goldman LB
    J Surg Res; 1979 Apr; 26(4):400-3. PubMed ID: 431058
    [No Abstract]   [Full Text] [Related]  

  • 23. [Chemotherapy of prostatic cancer].
    Portnoĭ AS
    Vopr Onkol; 1985; 31(9):3-12. PubMed ID: 2931901
    [No Abstract]   [Full Text] [Related]  

  • 24. Radiotherapy and concomitant chemoradiotherapy in the NB rat prostate adenocarcinoma model.
    Klump R; Pieters RS; Smith JJ; Badalament RA; Drago JR
    In Vivo; 1989; 3(2):109-11. PubMed ID: 2519835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined cyclophosphamide chemotherapy and maltose tetrapalmitate immunotherapy in the treatment of transplanted bladder and prostate carcinoma of the rat.
    Ibrahiem EH; Nigam VN; Brailovsky CA; Backman BD; Elhilali MM
    Cancer Res; 1984 Feb; 44(2):536-42. PubMed ID: 6537897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemotherapy of advanced carcinoma of the prostate with 5-fluorouracil, cyclophosphamide and adriamycin.
    Merrin C; Etra W; Wajsman Z; Baumgartner G; Murphy G
    J Urol; 1976 Jan; 115(1):86-8. PubMed ID: 1107604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemotherapeutic and hormonal considerations of the Nb rat prostatic adenocarcinoma model.
    Drago JR; Goldman LB; Gershwin ME
    Prog Clin Biol Res; 1980; 37():325-63. PubMed ID: 7384092
    [No Abstract]   [Full Text] [Related]  

  • 28. The Nb rat: prostatic adenocarcinoma model.
    Drago JR; Ikeda RM; Maurer RE; Goldman LB; Tesluk H
    Invest Urol; 1979 Mar; 16(5):353-9. PubMed ID: 429131
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase II trial of 5-fluorouracil (NSC-19893), adriamycin (NSC-123127), and methotrexate (NSC-740) in lung adenocarcinoma.
    Lowitz BB
    Cancer Treat Rep; 1976 May; 60(5):623-4. PubMed ID: 991153
    [No Abstract]   [Full Text] [Related]  

  • 30. [Sequential chemotherapy based on the hypothesis of a circadian rhythm of tumor proliferation].
    Focan C
    Nouv Presse Med; 1975 Nov; 4(38):2709-12. PubMed ID: 1105421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Nb rat prostatic adenocarcinoma's dose response to methotrexate and adriamycin.
    Drago JR; Palmer J
    J Surg Oncol; 1983 Nov; 24(3):215-7. PubMed ID: 6632910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo model systems for assessing an anti-cancer drug: responses of autochthonous and transplanted prostate tumors to cyclophosphamide.
    Pollard M; Luckert PH
    Anticancer Res; 1990; 10(1):33-6. PubMed ID: 2334140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies on the chemotherapy of experimental brain tumors: evaluation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea, vincristine, and 5-fluorouracil.
    Shapiro WR
    J Natl Cancer Inst; 1971 Feb; 46(2):359-68. PubMed ID: 4256014
    [No Abstract]   [Full Text] [Related]  

  • 34. Combination chemotherapy in a prostate tumor model: Nb rat prostatic adenocarcinoma model.
    Drago JR; Worgul T; Gershwin ME
    J Surg Oncol; 1981; 16(4):353-63. PubMed ID: 7195962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nb rat prostate adenocarcinoma model: metastasis.
    Drago JR; Curley RM; Sipio JC
    Anticancer Res; 1985; 5(2):193-6. PubMed ID: 2581494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct effects of chemotherapeutic agents on rat prostate tumor clonogenic cells.
    Geldof AA; Rao BR; de Voogt HJ
    Anticancer Res; 1986; 6(4):837-40. PubMed ID: 3752961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclophosphamide-adriamycin combination chemotherapy of transplantable murine tumors.
    Corbett TH; Griswold DP; Mayo JG; Laster WR; Schabel FM
    Cancer Res; 1975 Jun; 35(6):1568-73. PubMed ID: 1131824
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of cyclophosphamide alone and scheduled methotrexate-5-fluorouracil combination chemotherapy on transplantable R-3327 prostatic adenocarcinoma in F1 hybrid male rat.
    Smith JB; Ghayad PY; Dhabuwala CB; Drelichman A; Pierce JM
    Urology; 1987 Aug; 30(2):143-6. PubMed ID: 3617298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transplantable mouse mammary adenocarcinoma 16/c as a model in experimental cancer therapy. III. Sensitivity to antitumor drugs.
    Rak J; Kuśnierczyk H; Strzadała L; Kłosiewicz S; Radzikowski C
    Arch Immunol Ther Exp (Warsz); 1989; 37(3-4):389-97. PubMed ID: 2639635
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cisplatin-MECY (methotrexate-leucovorin rescue plus cyclophosphamide) versus cisplatin-CHAD (cyclophosphamide, hexamethylmelamine, doxorubicin, and cisplatin) as initial chemotherapy in stage III-IV ovarian adenocarcinoma.
    Barlow JJ; Lele SB
    Cancer Treat Rep; 1984 Dec; 68(12):1433-8. PubMed ID: 6439408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.